US Stock MarketDetailed Quotes
JNJ Johnson & Johnson
- 149.560
- +0.440+0.30%
Close Apr 23 16:00 ET
- 149.210
- -0.350-0.23%
Pre 07:04 ET
360.41BMarket Cap9.38P/E (TTM)
150.490High148.210Low10.11MVolume149.860Open149.120Pre Close1.51BTurnover0.42%Turnover Ratio10.90P/E (Static)2.41BShares172.00552wk High5.24P/B359.69BFloat Cap142.71252wk Low4.76Dividend TTM2.41BShs Float176.340Historical High3.18%Div YieldTTM1.53%Amplitude12.527Historical Low149.583Avg Price1Lot Size
About Johnson & Johnson Company
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
Company Profile
SymbolJNJ
Company NameJohnson & Johnson
Listing DateSep 25, 1944
Founded1887
CEOMr. Joaquin Duato
MarketNYSE
Employees131900
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressOne Johnson & Johnson Plaza
CityNew Brunswick
ProvinceNew Jersey
CountryUnited States of America
Zip Code08933
Phone1-732-524-0400
Websitehttp://www.jnj.com
Company Executives
- Name
- Position
- Salary
- Joaquin Duato
- Chairman of the Board and Chief Executive Officer
- 28.40M
- Joseph J. Wolk
- Executive Vice President and Chief Financial Officer
- 13.91M
- Kathryn E. Wengel
- Executive Vice President and Chief Technical Operations & Risk Officer
- --
- James D. Swanson
- Executive Vice President and Chief Information Officer
- --
- Robert J. Decker, Jr
- Controller and Chief Accounting Officer
- --
- Dr. Peter M. Fasolo, PhD
- Executive Vice President and Chief Human Resources Officer
- 7.50M
- William N. Hait, M.D.,PhD
- Executive Vice President, Chief External Innovation and Medical Officer
- --
- Vanessa Broadhurst
- Executive Vice President, Global Corporate Affairs
- --
- Elizabeth Forminard
- Executive Vice President and General Counsel
- --
- Jennifer L. Taubert
- Executive Vice President and Worldwide Chairman, Innovative Medicine
- 11.00M
- Dr. John C. Reed,M.D.,PhD
- Executive Vice President, Innovative Medicine, R&D
- 20.65M
- Timothy Schmid
- Executive Vice President and Worldwide Chairman, MedTech
- --
- Dr. Nadja Y West, M.D.
- Independent Director
- 340.00K
- Marillyn A. Hewson
- Independent Director
- 360.00K
- Hubert Joly
- Independent Director
- 320.00K
- Darius E. Adamczyk
- Independent Director
- 340.00K
- Dr. Paula A. Johnson,M.D.
- Independent Director
- 352.97K
- Eugene A. Woods
- Independent Director
- 89.15K
- Dr. Mary C. Beckerle, PhD
- Independent Director
- 355.00K
- Mark A. Weinberger
- Independent Director
- 340.00K
- D. Scott Davis
- Independent Director
- 350.00K
- Dr. Mark B. McClellan, M.D.,PhD
- Independent Director
- 320.00K
- Dr. Jennifer A. Doudna
- Independent Director
- 320.00K
- Anne M. Mulcahy
- Lead Independent Director
- 410.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
